Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114816
Status:
COMPLETED
Last Update Posted:
2007-05-21
First Post:
2005-06-17
Brief Title:
Docetaxel Followed by CEF Cyclophosphamide Epirubicin and 5-Fluorouracil Compared to Docetaxel and Capecitabine Followed by CEX Cyclophosphamide Epirubicin and Capecitabine as Adjuvant Treatment for Breast Cancer
Sponsor:
Organization:
Finnish Breast Cancer Group